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INTRODUCTION
In this world, errors due to look-alike or sound-alike 
medication names are common and are responsible 
for thousands of deaths and millions of dollars in cost 
every year. A study has shown that up to 25% of all 
medication errors are attributed to name confusion and 
33% to packaging and labeling confusion. Thousands of 
medication name pairs have been confused based on similar 
appearances or sounds when written or spoken or have been 
identified as having the potential for confusion.  [1] According 
to report of the Institute of Medicine of the National 
Academies, “Preventing Medication Errors,” approximately 
1.5 million preventable adverse drug events occur each 
year. However, more than one-third of adverse drug events 
take place in outpatient settings at a cost approaching $1 
billion annually.  [2] It has been expected that a large share of 
outpatient medication errors occur as a result of patients 
themselves not administering a medicine as intended.[3]
NEED OF ATTENTION
According to the Institute of Medicine (IOM) report, cited 
poor labeling as a central cause for medication errors.  [4] 
Attention to the origin causes of medication errors leading 
to adverse events has most often been attributed to the 
providers and health care systems contributing character 
to errors during the prescribing, ordering, dispensing, or 
administering of a medicine.[5,6] The reason for focusing 
on those causes may be that most studies investigating 
medication errors have been conducted in inpatient hospitals 
or nursing homes.[7] Studies have shown that variability in drug 
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labeling and the use of certain terminology can adversely 
affect a patient’s understanding of medication instructions.  [8,9] 
The Joint Commission and the National Coordinating 
Council for Medication Error Reporting and Prevention 
(NCC MERP) have provided guidance for physicians on 
how to write “Sig.” messages, with recommendations to 
avoid certain wording, acronyms, and Latin phrases that 
have been linked to medication errors.[10,11] Chronically sick 
patients and the elderly are at the greatest risk for experiencing 
medication errors as they take more prescription drugs per 
annum than younger and healthier patients, and visual or 
cognitive impairments by age may limit reading ease and 
comprehension.[12-16] Patients growingly self-manage greater 
numbers of prescriptions and over-the-counter medications. 
The jeopardy for miscommunication and error may be 
supplementally compounded since the average older adult 
sees several different health care providers annually.[17]
VARIABILITY AND QUALITY OF MEDICATION 
CONTAINER LABELS
Medication errors occur regularly and poor medication 
labeling is cited as a potential cause. The experts studied and 
assessed the format, content, and variability of prescription 
drug container labels dispensed in a population. A study has 
been done by William H et al. and they evaluated 85 labels 
after excluding 11-Ibuprofen prescriptions that were filled 
with over-the counter containers that lacked labels printed 
at the pharmacy. The pharmacy name or logo was the 
most prominent item on 71 (84%) of the labels, with a 
mean font size of 13.6 point. Font sizes were lesser for 
medication instructions (9.3 point), medication name (8.9 
point), and warning and instruction stickers (6.5 point). 
Color, boldfacing, and highlighting were most often used to 
identify the pharmacy and items most useful to pharmacists. 
While the content of the main label was generally consistent, 
there was substantial variability in the content of instruction 
and warning stickers from different pharmacies, and 
independent pharmacies were less likely to use such stickers. 
None of the Ibuprofen containers were delivered with Food 
and Drug Administration-approved medication guides, as 
required by law. After this study, they concluded that the 
format of most container labels emphasizes pharmacy 
characteristics and items frequently used by pharmacists 
rather than use instructions or medication warnings. The 
content of warning and instruction stickers is highly variable 
depending on the pharmacy selected.[18]
PHYSICIAN-PATIENT COMMUNICATION
Most of the physicians with official responsibilities to convey 
instructions on proper medication use have frequently been 
found to be ineffective in their role. Research has shown 
that physicians frequently miss opportunities to counsel 
their patients on how to self-administer their medicines.  [19,20] 
Health literacy studies have also highlighted that many 
physicians do not communicate health and treatment 
information in a manner that can be understood by 
patients with limited literacy skills.[21] If the patient leaves 
the physician office without the information needed to 
correctly implement the prescribed regimen, the pharmacist, 
at the point of dispensing medicines, would be next in line 
to counsel patients. Studies have shown that pharmacists 
also often fail to orally communicate detailed information 
to patients to support their adherence with prescribed 
regimens.[22,23] The last opportunity for counseling is the 
container label and accompanying print materials such 
as container label, patient package inserts, consumer 
medication information, medication guides, etc., which 
have been found to be long, complex, and written at a level 
too difficult for a majority of patients, regardless of their 
literacy level, to comprehend and use.[24,25]
HEALTH LITERACY AND MEDICAL SAFETY
Several studies have found limited health literacy to be 
significantly associated with a poorer understanding of 
medication names, indications, and instructions.[26-28] 
Recently, health literacy was specifically well known 
within a seminal report released by the National Council 
for Patient Information and Education (NCPIE).[29] The 
report refers to health literacy as a national concern 
with regard to a patient’s understanding, safe use, and 
proper adherence to medication regimens.[29] A multi 
site study conducted by Davis et al. and they showed 
that among adults receiving primary care at community 
health centers, there was a high prevalence of patients, 
especially those with limited literacy, misunderstanding 
apparently simple dose instructions provided on the 
primary label of medication containers.  [30] In this study, 
46% of adults misunderstood at least one prescription 
container label they encountered. The problem extends 
to the auxiliary sticker labels that provide accompanying 
warnings and directions for use of the medicine.[29,31] 
Other studies demonstrated that over half (53%) of 
patients, especially those with limited literacy, had 
difficulty interpreting text and icons usually used on 
auxiliary warning instructions.[29]
PARTICIPANTS OF THIS ERROR SYSTEM
The problems associated with prescription container 
labeling are ultimately the result of an apparent lack 
of standards and regulatory errors. This is a matter of J Young Pharm Vol 2 / No 1  109
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patient safety and successful therapeutic outcomes. A lack 
of integration among the existing health information 
systems that support a rising number of prescribers and 
the majority of dispensing pharmacies also add to labeling 
difficulties.[31]
The prescriber
The container label offers perhaps the only written 
documentation of dosage or usage directions for 
the patient, which is imparted through the physicians’ 
prescription. In most pharmacies today, whatever the 
physician writes is what is transcribed onto the container 
label. Although there may be a finite number of ways a 
prescription can be written, the same dose and frequency 
schedule for a prescribed drug may be written in several 
different ways. Today most of the physicians also use a 
range of Latin abbreviations to identify drug dose and 
frequency, rendering the prescription uninterruptable to 
most patients. This becomes especially challenging as many 
patients, especially the elderly, may have more than one 
health care provider prescribing medicines. It is unclear 
if physicians and other prescribing health care providers 
receive adequate training in writing prescriptions. Although 
electronic prescribing offers options for enhanced safety, 
it is still necessary to determine what physician prescribing 
notations optimize patient’s safe and effective use of 
medications.[32]
The dispensing pharmacy
In a modern study, conducted by Shrank et al. and they 
showed after gathered data from identically written 
prescriptions filled for four commonly prescribed 
drugs (Atorvastatin, Alendronate, Trimethoprim-
Sulfamethoxazole, and Ibuprofen) in six different 
pharmacies (two chains, two independent, and two grocery 
stores) in four diverse cities.[33] The evaluation of the 
format of labels on filled prescriptions suggested that 
labels were not designed to optimize patient understanding 
of medication administration instructions or warnings. 
The largest item on nearly all of the labels was the 
pharmacy logo. The label items that were emphasized 
were useful to identify the pharmacy and to enhance the 
practice of the pharmacist, but not to help patients to 
safely and appropriately administer medication. In the 
reported study, between 8% and 25% of containers did 
not include any warning or instruction stickers. Among 
the 85 labels evaluated, dose frequency was omitted on 
6% of instructions.[34] A total of 27% of the translated 
instructions had a lexile reading grade level above a high 
school level.[31]
HEALTH INFORMATION TECHNOLOGY: CAN IT 
REDUCE THIS MEDICATION ERROR
To compare handwritten and electronically generated 
prescription drug instructions, by Stephen et al. conducted 
a study and they assessed the variability of medication 
instructions and their compliance with Joint Commission and 
NCC MERP recommendations at the point of prescribing 
three medications with the common dosage instruction, 
“Take one tablet a day.” And they compared 85 handwritten 
prescriptions from a hospital in the Southeast with 1326 
electronically generated prescriptions from an academic 
practice in the Midwest. The majority (61%) of handwritten 
prescriptions did not adhere to Joint Commission and 
NCC MERP recommendations to avoid Latin phrases. In 
contrast, only 1% of electronically generated prescriptions 
contained Latin abbreviations. Electronically generated 
prescriptions also had less variability than handwritten 
prescriptions. Most electronically generated medication 
instructions (93%) were default Sig. messages, which 
automatically appear within the text box in the electronic 
health record (EHR). A recent 2008 IOM report has 
provided clear evidence to support best practices for drug 
labeling. The use of EHRs offers an opportunity to adopt 
these practices and reduce instruction variability and the 
use of Latin terminology. Efforts should be taken to set 
standards for the writing of Sig. messages to promote 
patient safety and improve patient understanding of 
medication instructions, thereby reducing the number of 
preventable adverse drug events.[35,36]
NEED TO IMPROVE THIS MEDICATION ERROR
There is evidence available to detail “best practices” for 
improving dosage or usage instructions written by the 
prescribing physician and the format and content of 
prescription medication container labels designed by the 
dispensing pharmacy.[37] The use of standard and more 
explicit dosage or usage instructions can improve patients’ 
functional understanding of how and when to take a 
medicine.[30] Evidences are available for best practices in 
labeling format and content, such as increasing font size, 
using clear and simple language, using headers, and placing 
a more appropriate emphasis on organizing label content 
around what is most important for patients such as drug 
name, dose, dosage or usage instructions, patient name, 
doctor name, quantity, refill information, and provider 
content such as pharmacy name, logo and national drug 
code number should be in optimal font size. A complete 
list of evidence-based, recommended standards for format, 
content, and instruction is as follows:[37]110   J Young Pharm Vol 2 / No 1
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1.  Use explicit text to describe dosage and interval in 
instructions.
2.  Use a universal medication schedule (UMS) to convey 
and simplify dosage and use instructions.
3.  Organize labels in a patient-centered manner.
4.  According to need, include indication for use.
5.  Simplify language, avoiding unfamiliar words or medical 
jargon.
6.  Improve typography, use larger, sans serif font.
7.  When applicable, use numeric versus alphabet 
characters.
8.  Use typographic cues (bolding and highlighting) for 
patient content only.
9.  Use horizontal text only.
10. Use a standard icon system for signaling and organizing 
auxiliary warnings and instructions.
CONCLUSION
A complete review of the published literature to 
evaluate the data regarding the best possible content and 
format of prescription labels might improve readability, 
understanding, and medication use. The evidence suggests 
that patients request information about a medication’s 
indication, expected benefits, duration of therapy, and a 
meticulous list of potential adverse effects. The evidence 
about label format supports the use of larger fonts, 
lists, headers, and white space, using simple language 
and logical organization to improve readability and 
comprehension. Patients must be able to easily realize 
how to use prescription drugs correctly. Standardizing 
and integrating drug labeling must be a central goal 
to ensure that best practices are implemented because 
evidence is already available to target improvements. This 
should be viewed as a short-term goal for policymakers, 
and some states have already made evolution to this 
end. In the long term, additional challenges for drug 
labeling include efforts to seek labeling concordance 
in other languages because not all prescription drug 
information and directions are presently available to 
non-English speakers. A formative response to labeling 
troubles would also extend to addressing how health care 
providers communicate to patients the information that is 
required to safely administer prescribed medicines. Mostly, 
health technology used by an increasing number of 
providers at the point of writing the prescription should 
be incorporated with the software used by dispensing 
pharmacies to fill it and print out the labeling components. 
This would provide another layer of quality assurance 
that could reduce variability and the risk that directions 
become lost in conversion.
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